{"id":1934,"date":"2025-09-18T23:41:03","date_gmt":"2025-09-18T23:41:03","guid":{"rendered":"https:\/\/www.finznest.com\/blog\/13-undervalued-healthcare-stocks-poised-to-soar-as-fed-signals-more-rate-cuts\/"},"modified":"2025-09-18T23:41:03","modified_gmt":"2025-09-18T23:41:03","slug":"13-undervalued-healthcare-stocks-poised-to-soar-as-fed-signals-more-rate-cuts","status":"publish","type":"post","link":"https:\/\/www.finznest.com\/blog\/13-undervalued-healthcare-stocks-poised-to-soar-as-fed-signals-more-rate-cuts\/","title":{"rendered":"13 Undervalued Healthcare Stocks Poised to Soar as Fed Signals More Rate Cuts"},"content":{"rendered":"
\n

As widely anticipated, the cut rates by 25 basis points on Wednesday, and its forecasts still favor two further rate cuts by the end of the year.<\/p>\n

Admittedly, the 50bp rate cut some had hoped for did not materialize, but last night\u2019s Fed decision still marks the start of a rate-cutting cycle. What\u2019s more, given Trump\u2019s pressure for lower rates, the Fed is more likely to exceed market than disappoint them.<\/p>\n

Against this backdrop, healthcare stocks could prove to be wise bets. First of all, it\u2019s worth noting that Health Care is the worst-performing sector in the S&P 500 this year, which suggests it has more room to grow than other overvalued sectors such as Technology.<\/p>\n

What\u2019s more, there are also several specific reasons why the Fed\u2019s rate cut could benefit healthcare stocks.<\/p>\n

In particular, lower rates reduce the discount rate applied to future earnings, which mechanically increases the valuation of companies with long-term growth expectations. In the healthcare (NYSE:XLV) sector, biotech and R&D companies benefit directly from this phenomenon.<\/p>\n

Finally, we must also consider the reasons behind the Fed\u2019s rate cut. The central bank lowered rates not to celebrate the return of to target, but to support an increasingly troubled labor market, raising fears of a period of economic slowdown.<\/p>\n

Yet in such climates, healthcare benefits from stable medical demand, and investors turn to stocks offering stable growth and steady dividends, a profile often found in the largest healthcare companies.<\/p>\n

Which are the best healthcare stocks to buy to take advantage of the Fed\u2019s rate cut?<\/strong><\/h2>\n

We set out to find the best US healthcare stocks to buy over the coming months, using the Investing.com screener. Specifically, we looked for US healthcare stocks with a market capitalization in excess of $1 billion, and with a potential upside of over 40%<\/strong> according to InvestingPro Fair Value, and an InvestingPro health score of over 3\/5<\/strong>.<\/p>\n

Here\u2019s what it looks like in terms of screener parameters:<\/p>\n

<\/p>\n

InvestingPro Fair Value calculates an intelligent average of several recognized valuation models for each stock on the market. The health score, on the other hand, is based on several key financial metrics and peer comparisons to assess companies\u2019 level of financial strength.<\/p>\n

This research enabled us to identify 13 stocks: <\/strong><\/p>\n

\"List<\/strong><\/p>\n

Are you an InvestingPro, plan Pro + member? Click on this link to access this custom screen.<\/em><\/strong><\/p>\n

According to InvestingPro Fair Value, these stocks could climb from +40.1% to +68.9%<\/strong>. What\u2019s more, some of these stocks also show significant upside potential according to analysts, including 5 which they believe could rise by more than 40%.<\/strong><\/p>\n